RicercaInizia una nuova ricerca
NOTA: è possibile cercare una corrispondenza esatta usando i doppi apici, ad es: "evoluzione della specie". Qualora si cerchi un identificativo, è consigliabile cercarlo in due modi differenti: tra apici con caratteri speciali es: "978-94-6366-274" oppure senza caratteri speciali solo come sequenza numerica: es 978946366274.
. The level of HER2/neu amplification may have a correlation with some relevant histopathologcal features of early stage breast cancer
2006-01-01 Gullo, G; Bettio, D; Masci, G; Torri, V; Di Tommaso, L; Banna, G; Santoro, A
48P The relationship among bowel FDG-PET uptake, pathological complete response, and the influence of eating and exercise habits in breast cancer patients undergoing neoadjuvant chemotherapy
2022-01-01 Tiberio, P.; Antunovic, L.; Gaudio, M.; Viganò, A.; Pastore, M.; Miggiano, C.; Jacobs, F.; Benvenuti, C.; Farina, E.; Chiti, A.; Santoro, A.; De Sanctis, R.
A. Micrometastasis in sentinel (SLN) and non sentinel lymph nodes of breast cancer: an update including clinico-pathologic impact and survaival
2006-01-01 Masci, G; Di Tommaso, L; Del Prato, I; Orefice, S; Rubino, A; Morenghi, E; Salvini, P; Alloisio, M; Morenghi, E; Roncalli, M; Santoro, A
A. Micrometastasis in sentinel (SLN) and non sentinel lymph nodes of breast cancer: an update including clinico-pathologic impact and survaival
2005-01-01 Masci, G; Di Tommaso, L; Del Prato, I; Orefice, S; Rubino, A; Morenghi, E; Salvini, P; Alloisio, M; Morenghi, E; Roncalli, M; Santoro, A.
Can We Predict the Benefit of the 70-Gene Signature in the Choice of Adjuvant Systemic Treatment for ER Positive, HER2 Negative Tumors in Daily Practice? A Single Institution Experience
2011-01-01 Torrisi, R; Garcia-Etienne, Ca; Losurdo, A; Morenghi, E; Di Tommaso, L; Gatzemeier, W; Sagona, A; Rossetti, C; Eboli, M; Rubino, A; Barbieri, E; Andreoli, C; Orefice, S; Gandini, C; Masci, G; Santoro, A; Tinterri, C
Carbon-11-methionine PET-CT as an imaging biomarker in brain gliomas eligible for surgery
2014-01-01 Lopci, E; Bello, L; Olivari, L; Raneri, F; Simonelli, M; Riva, M; Navarria, P; Zucali, Pa; Colombo, P; Scorsetti, M; Santoro, A; Chiti, A
Changes in shedding of soluble tumor necrosis factor receptors (sR1/R2) and in dynamic MRI as early predictors of outcome with NGR-hTNF
2013-01-01 Zucali, Pa; Simonelli, M; De Vincenzo, F; Santoro, A; Lambiase, A; Bordignon, C
Characterization of a young women population affected with breast cancer and tested for BRCA1/BRCA2 gene mutations: a monocentric series
2012-01-01 Zuradelli, M; Ripamonti, Cb; Torrisi, R; Basilico, V; Tinterri, C; Testori, A; Di Tommaso, L; Bernard, L; Radice, P; Santoro, A
Final results from ARQ 197-114: A phase 1b safety trial evaluating ARQ 197 in cirrhotic patients (pts) with hepatocellular carcinoma (HCC)
2010-01-01 Zucali, P; Santoro, A; Rodriguez-Lope, C; Simonelli, M; Camacho, Lh; Senzer, Nn; Bolondi, L; Lamar, M; Abbadessa, G; Schwartz, Be
High incidence of hypocalcemia in patients with bone metastases from different kinds of neoplasms, treated with zoledronate
2006-01-01 Zuradelli, M; Masci, G; Tronconi, Mc; Rimassa, L; Gullo, G; Pressiani, T; Simonelli, M; Morenghi, E; Biancofiore, G; Santoro, A
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| . The level of HER2/neu amplification may have a correlation with some relevant histopathologcal features of early stage breast cancer | 1-gen-2006 | Gullo, G; Bettio, D; Masci, G; Torri, V; Di Tommaso, L; Banna, G; Santoro, A | |
| 48P The relationship among bowel FDG-PET uptake, pathological complete response, and the influence of eating and exercise habits in breast cancer patients undergoing neoadjuvant chemotherapy | 1-gen-2022 | Tiberio, P.; Antunovic, L.; Gaudio, M.; Viganò, A.; Pastore, M.; Miggiano, C.; Jacobs, F.; Benvenuti, C.; Farina, E.; Chiti, A.; Santoro, A.; De Sanctis, R. | |
| A. Micrometastasis in sentinel (SLN) and non sentinel lymph nodes of breast cancer: an update including clinico-pathologic impact and survaival | 1-gen-2006 | Masci, G; Di Tommaso, L; Del Prato, I; Orefice, S; Rubino, A; Morenghi, E; Salvini, P; Alloisio, M; Morenghi, E; Roncalli, M; Santoro, A | |
| A. Micrometastasis in sentinel (SLN) and non sentinel lymph nodes of breast cancer: an update including clinico-pathologic impact and survaival | 1-gen-2005 | Masci, G; Di Tommaso, L; Del Prato, I; Orefice, S; Rubino, A; Morenghi, E; Salvini, P; Alloisio, M; Morenghi, E; Roncalli, M; Santoro, A. | |
| Can We Predict the Benefit of the 70-Gene Signature in the Choice of Adjuvant Systemic Treatment for ER Positive, HER2 Negative Tumors in Daily Practice? A Single Institution Experience | 1-gen-2011 | Torrisi, R; Garcia-Etienne, Ca; Losurdo, A; Morenghi, E; Di Tommaso, L; Gatzemeier, W; Sagona, A; Rossetti, C; Eboli, M; Rubino, A; Barbieri, E; Andreoli, C; Orefice, S; Gandini, C; Masci, G; Santoro, A; Tinterri, C | |
| Carbon-11-methionine PET-CT as an imaging biomarker in brain gliomas eligible for surgery | 1-gen-2014 | Lopci, E; Bello, L; Olivari, L; Raneri, F; Simonelli, M; Riva, M; Navarria, P; Zucali, Pa; Colombo, P; Scorsetti, M; Santoro, A; Chiti, A | |
| Changes in shedding of soluble tumor necrosis factor receptors (sR1/R2) and in dynamic MRI as early predictors of outcome with NGR-hTNF | 1-gen-2013 | Zucali, Pa; Simonelli, M; De Vincenzo, F; Santoro, A; Lambiase, A; Bordignon, C | |
| Characterization of a young women population affected with breast cancer and tested for BRCA1/BRCA2 gene mutations: a monocentric series | 1-gen-2012 | Zuradelli, M; Ripamonti, Cb; Torrisi, R; Basilico, V; Tinterri, C; Testori, A; Di Tommaso, L; Bernard, L; Radice, P; Santoro, A | |
| Final results from ARQ 197-114: A phase 1b safety trial evaluating ARQ 197 in cirrhotic patients (pts) with hepatocellular carcinoma (HCC) | 1-gen-2010 | Zucali, P; Santoro, A; Rodriguez-Lope, C; Simonelli, M; Camacho, Lh; Senzer, Nn; Bolondi, L; Lamar, M; Abbadessa, G; Schwartz, Be | |
| High incidence of hypocalcemia in patients with bone metastases from different kinds of neoplasms, treated with zoledronate | 1-gen-2006 | Zuradelli, M; Masci, G; Tronconi, Mc; Rimassa, L; Gullo, G; Pressiani, T; Simonelli, M; Morenghi, E; Biancofiore, G; Santoro, A |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile
Opzioni
Scopri
Tipologia
- 4 Contributo in Atti di Convegno ... 47
- 4 Contributo in Atti di Convegno ... 35
- 4 Contributo in Atti di Convegno ... 10
- 4 Contributo in Atti di Convegno ... 2
Data di pubblicazione
- 2020 - 2022 5
- 2010 - 2019 34
- 2005 - 2009 8
Rivista
- JOURNAL OF CLINICAL ONCOLOGY 19
- ANNALS OF ONCOLOGY 11
- EUROPEAN JOURNAL OF CANCER 2
- EUROPEAN JOURNAL OF CANCER. SUPPL... 2
- JOURNAL OF THORACIC ONCOLOGY 2
- CANCER RESEARCH 1
- EUROPEAN ASSOCIATION OF NEUROONCO... 1
- EUROPEAN JOURNAL OF NUCLEAR MEDIC... 1
- INTERNATIONAL JOURNAL OF RADIATIO... 1
- NEURO-ONCOLOGY 1
Lingua
- eng 7
- ita 1
Accesso al fulltext
- no fulltext 47